Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Diagnostic Equipment

Oxoid Agglutinating Sera Recalled for Potential Salmonella Misidentification

Agency Publication Date: April 22, 2026
Share:
Sign in to monitor this recall

Summary

Remel Europe Ltd. is recalling 117 units of Oxoid Agglutinating Sera, Salmonella 9-0 used in laboratory testing. The affected product lots may fail to perform correctly, showing a cross-reaction within 60 seconds that could lead to the misidentification of a Salmonella 9-O serotype as a 2-O serotype. This recall affects 16 specific lots distributed across 15 U.S. states and worldwide. No incidents or injuries have been reported to date.

Risk

The laboratory diagnostic sera may show a false-positive cross-reaction, which can cause laboratory professionals to misidentify the specific strain of Salmonella being tested. This misidentification could potentially lead to incorrect medical or epidemiological data.

What You Should Do

  1. Identify the affected product by checking the packaging for 'Oxoid Agglutinating Sera, Salmonella 9-0' with catalog number R30957301.
  2. Verify the lot numbers and UDI-DI on your product label. Affected UDI-DI is 05056080500270. See the Affected Products section below for the full list of affected codes.
  3. Stop using the recalled product immediately.
  4. Contact Remel Europe Ltd. or your distributor to arrange for a return, replacement, or correction of the affected laboratory materials.
  5. Call the FDA Consumer Complaint hotline at 1-888-463-6332 (1-888-INFO-FDA) for additional information or to report concerns.

Your Remedy Options

๐Ÿ“‹Other Action
How to: Stop using the recalled product. Contact the manufacturer or your distributor to arrange return, replacement, or correction.

Affected Products

Product: Oxoid Agglutinating Sera, Salmonella 9-0
Model / REF:
R30957301
Lot Numbers:
6172600
6172741
6171393
6150168
6107767
3766399
3766400
3780497
3719592
3709358
6266130
6253410
6260215
6222350
6233859
6233858
UDI:
05056080500270

Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 98652
Status: Active
Manufacturer: Remel Europe Ltd.
Sold By: Authorized laboratory distributors
Manufactured In: United Kingdom
Units Affected: 117
Distributed To: Alabama, California, Florida, Iowa, Illinois, Indiana, Michigan, Minnesota, Missouri, North Carolina, Nebraska, Ohio, South Dakota, Texas, Washington

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.